NEW YORK and CLEVELAND, Aug. 10, 2021 (Globe NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-built-in chief in gene and mobile therapy, nowadays declared
NEW YORK and CLEVELAND, Aug. 10, 2021 (Globe NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-built-in chief in gene and mobile therapy, nowadays declared